Roy Zhang

Roy Zhang

Auto-generated profile, based on publicly available information

Roy Zhang

Molecular Immunity Unit, University of Cambridge Department of Medicine, Cambridge, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2024 in Kidney International
Verified
Journal Article
Open access
RZRoy Zhang
Roy Zhang
PTPatrick B. Trotter
Patrick B. Trotter
JMJames McCaffrey
James McCaffrey
RFRory Fitzroy
Rory Fitzroy
GTGiorgio Trivioli
Giorgio Trivioli
MCMenna R. Clatworthy
Menna R. Clatworthy
Organ shortage is a major challenge in kidney transplantation but the use of older donors, often with co-morbidities, is hampered by inconsistent outcomes. Methods of accurately stratifying marginal donor organs by clinical and histological assessment are lacking. To better understand organ variability, we profiled the transcriptomes of 271 kidneys from deceased donors at retrieval. Following correction for biopsy composition, we assessed molecular pathways that associated with delayed, and sub-optimal one-year graft function. Analysis of cortical biopsies identified an adaptive immune gene-rich module that significantly associated with increasing age and worse outcomes. Cellular deconvolution using human kidney reference single cell transcriptomes confirmed an increase in kidney-specific B and T cell signatures, as well as kidney macrophage, myofibroblast and fibroblast gene sets in this module. Surprisingly, innate immune pathway and neutrophil gene signature enrichment was associated with better outcomes. Thus, our work uncovers cellular molecular features of pathological organ ageing, identifiable at kidney retrieval, with translational potential.

11 July 2022 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Open access
PDF file
FFFaye Forsyth
Faye Forsyth
SMSandra Mulrennan
Sandra Mulrennan
JBJenni Burt
Jenni Burt
PHPeter Hartley
Peter Hartley
IKIsla Kuhn
Isla Kuhn
CDChristi Deaton
Christi Deaton
To determine what dietary interventions have been tested in heart failure with preserved ejection fraction (HFpEF), the modulation method, and outcomes employed and to summarize any evidence for benefit. We performed key word searches in five bibliographic databases from 2001 to 2021, to identify randomized or experimental dietary interventions tested in HFpEF or mixed heart failure (HF) samples. Study characteristics were summarized according to population, intervention, comparator, outcome categories and intervention complexity was assessed. Twenty-five clinical investigations were retrieved; only 10 (40%) were conducted exclusively in HFpEF; the remainder enrolled mixed HF samples. Most studies employed either highly tailored prescribed diets (n = 12, 48%) or dietary supplementation (n = 10, 40%) modalities. Dietary pattern interventions (n = 3, 12%) are less well represented in the literature. Heterogeneity made pooling studies challenging. Better reporting of baseline characteristics and the use of standardized HF lexicon would ensure greater confidence in interpretation of studies involving mixed HF populations. The field would benefit greatly from explicit reporting of the biological mechanism of action (e.g. the causal pathway) that an intervention is designed to modulate so that studies can be synthesized via their underlying mechanism of action by which diet may affect HF. An extension of the current set of core outcomes proposed by the European Society of Cardiology Heart Failure Association would ensure dietary clinical endpoints are more consistently defined and measured. PROSPERO: CRD42019145388.

1 December 2022 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Open access
PDF file
FFFaye Forsyth
Faye Forsyth
SMSandra Mulrennan
Sandra Mulrennan
JBJenni Burt
Jenni Burt
PHPeter Hartley
Peter Hartley
IKIsla Kuhn
Isla Kuhn
CDChristi Deaton
Christi Deaton
Aims: To determine the efficacy of dietary interventions in Heart Failure with preserved Ejection Fraction (HFpEF). Method and results: Keyword searches were performed in five bibliographic databases to identify randomized or controlled studies of dietary interventions conducted in HFpEF or mixed heart failure (HF) samples published in the English language. Studies were appraised for bias and synthesized into seven categories based on the similarity of the intervention or targeted population. The quality of the body of evidence was assessed via the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) framework. Twenty-five unique interventions were identified; 17 were considered for meta-analysis. Most studies were judged to be at high risk of bias. There was moderate-quality evidence that caloric restriction led to clinically meaningful improvements in blood pressure and body weight. There was moderate-quality evidence that carbohydrate restriction resulted in meaningful reductions in blood pressure. There was very low-quality evidence that protein supplementation improved blood pressure and body weight and moderate-quality evidence for clinically meaningful improvements in function. Conclusions: While some types of dietary interventions appeared to deliver clinically meaningful change in critical outcomes; the study heterogeneity and overall quality of the evidence make it difficult to make firm recommendations. Greater transparency when reporting the nutritional composition of interventions would enhance the ability to pool studies. Registration: PROSPERO CRD42019145388.

3 March 2020
Verified
Conference Paper
Closed access
PDF file
XCXuxin Chen
Xuxin Chen
RZRoy Zhang
Roy Zhang
KFKar-Ming Fung
Kar-Ming Fung
HLHong Liu
Hong Liu
Bin ZhengBin Zheng
Bin Zheng
YQYuchen Qiu
Yuchen Qiu
Automatic classification of epithelium and stroma regions on histopathological images is critically important in digital pathology. Although many studies have been conducted in this research area, few investigations have been focused on model generalizability between different types of tissue samples. The objective of this study is to initially verify the classification effectiveness of a sufficiently optimized transfer model. Accordingly, two datasets were assembled, which contain 157 breast cancer images (Dataset I) and 11 ovarian cancer images (Dataset II), respectively. A computer aided detection (CAD) scheme was developed for this classification task. The scheme first divided each image into small regions of interest (ROI) containing only epithelium or stroma tissues, using multi-resolution super-pixel algorithm. Then, a total of 26 quantitative features were computed for each ROI, which were used as the input of five different machine learning classifiers, namely, linear support vector machine (SVM), linear discriminant analysis (LDA), logistic regression, decision tree and k-nearest neighbors (KNN). The scheme was trained and optimized on Dataset I, and five-fold cross validation strategy was utilized for performance evaluation. After the scheme was sufficiently optimized on Dataset I, it was applied “as is” on dataset II. The results of the breast cancer dataset show that linear SVM achieved the highest classification accuracy of 0.910. When applied on the 11 ovarian cancer cases (Dataset II), the SVM model achieved an average classification accuracy of 0.744. This preliminary study initially demonstrates the model transfer performance for epithelium-stroma classification task.